(3β,7β,12β,20Z )-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid

Cat. No.: X23-05-YM390

(3β,7β,12β,20Z )-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid

Synonym: (Z)-2-Methyl-4-oxo-6-[(3R,5S,7R,10R,12R,13S,14S,17S)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoic acid

  • CAS Number: 1961358-02-0
  • Compound CID: 154831610
Product Size
5 mg; 10 mg; 20 mg
Price
Datasheet
MSDS
Properties
Description
(3β,7β,12β,20Z )-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid is a lanostane triterpenoid that displays significant inhibitory effects on n LPS-induced BV-2 microglia cells.
Purity
≥95%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Applications
(3β,7β,12β,20Z )-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid is useful for its NO inhibitory activity on n LPS-induced BV-2 microglia cells.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.